# WIBOFA - Validation of SCT02 With ECG-App for Detection of AF

Study · id `cardio:ct-nct06351761` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06351761](<https://clinicaltrials.gov/study/NCT06351761>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06351761

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 373 participants.

## Technical summary

Registry record NCT06351761. Non-randomized; no masking; primary purpose basic science. Start 2024-06-03 (actual); primary completion 2025-06-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose basic science
- Phase: Not applicable
- Enrolled: 373 participants (enrolled count; ClinicalTrials.gov record NCT06351761, source copy `cardio:ctgov-nct06351761-2026-02-18`, retrieved 2026-10-26)
- Started: 2024-06-03 (actual) (ClinicalTrials.gov record NCT06351761, source copy `cardio:ctgov-nct06351761-2026-02-18`, retrieved 2026-10-26)
- Primary completion: 2025-06-10 (actual) (ClinicalTrials.gov record NCT06351761, source copy `cardio:ctgov-nct06351761-2026-02-18`, retrieved 2026-10-26)
- Completion: 2025-11-26 (actual) (ClinicalTrials.gov record NCT06351761, source copy `cardio:ctgov-nct06351761-2026-02-18`, retrieved 2026-10-26)
- Countries: United States; France (ClinicalTrials.gov record NCT06351761, source copy `cardio:ctgov-nct06351761-2026-02-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06351761-2026-02-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: WIBOFA - Validation of SCT02 With ECG-App for Detection of AF
- Acronym: WIBOFA
- Condition: Atrial Fibrillation
- Intervention (Device): Investigational Device (Withings SCT02) 30 second Electrocardiogram recording
- Intervention (Device): Reference Device (Schiller Cardiovit FT-1) 30 second Electrocardiogram recording
- Lead sponsor: Withings
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Withings (`cardio:org-withings`)

## Provenance

Content hash: 0d8a1b8fe93b9d6f01b5381f6073a2f0515c20edaf46b43cea17f52070fe0c4a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
